The frequencies of methylation for DRM/Gremlin and HPP1 were higher in advanced-stage bladder cancer cases (stages III–IV) than in early-stage cases (stages 0–II, P=0.03 and 0.003, respectively). The gene discussed is TMEFF2; the disease is urinary bladder cancer.